PlainRecalls
FDA Drug Moderate Class II Terminated

midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

Reported: October 11, 2023 Initiated: September 21, 2023 #D-0018-2024

Product Description

midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

Reason for Recall

Lack of assurance of sterility:

Details

Units Affected
419 50 mL syringes
Distribution
Nationwide in the USA
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1. Recalled by Central Admixture Pharmacy Services Inc. Units affected: 419 50 mL syringes.
Why was this product recalled?
Lack of assurance of sterility:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 11, 2023. Severity: Moderate. Recall number: D-0018-2024.